Moderate levels of serum hepatitis B virus DNA are associated with the highest risk of hepatocellular carcinoma in chronic hepatitis B patients-Reference-Cited by-同舟云学术

Moderate levels of serum hepatitis B virus DNA are associated with the highest risk of hepatocellular carcinoma in chronic hepatitis B patients

Published:2020-04-14 Issue:11 Volume:51 Page:1169-1179
ISSN:0269-2813
Container-title:Alimentary Pharmacology & Therapeutics
language:en
Short-container-title:Aliment Pharmacol Ther

Author:

Kim Gi-Ae¹²^ORCID,Han Seungbong³,Choi Gwang Hyeon¹⁴,Choi Jonggi¹,Lim Young-Suk¹^ORCID

Affiliation:

1. Department of Gastroenterology; Liver Center; Asan Medical Center; University of Ulsan College of Medicine; Seoul Republic of Korea

2. Department of Internal Medicine; Kyung Hee University School of Medicine; Seoul Republic of Korea

3. Department of Applied Statistics; Gachon University; Seongnam Republic of Korea

4. Department of Internal Medicine; Seoul National University Bundang Hospital; Seoul National University College of Medicine; Seongnam Republic of Korea

Funder

Korean National Health Clinical Research

the

Korean Health Technology R&D Project

National Evidence-based Healthcare Collaborating Agency

National Research Foundation of Korea

Ministry of Trade, Industry & Energy (MOTIE) of the Republic of Korea

Bayer

Gilead Sciences

Publisher

Wiley

Subject

Pharmacology (medical),Gastroenterology,Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/apt.15725/fullpdf

Reference36 articles.

1. Forecasting life expectancy, years of life lost, and all-cause and cause-specific mortality for 250 causes of death: reference and alternative scenarios for 2016-40 for 195 countries and territories;Foreman;Lancet,2018

2. Global elimination of chronic hepatitis;Thomas;N Engl J Med,2019

3. Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level;Chen;JAMA,2006

4. High risk of hepatocellular carcinoma and death in patients with immune-tolerant-phase chronic hepatitis B;Kim;Gut,2018

5. Management of chronic hepatitis B patients in immunetolerant phase: what latest guidelines recommend;Wong;Clin Mol Hepatol,2018

Cited by 59 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Canadian Association for the Study of the Liver Single Topic Conference on Hepatitis B Virus: ‘Progress toward hepatitis B elimination in Canada’;Canadian Liver Journal;2024-08-28

2. Estimating the key outcomes and hepatocellular carcinoma risk in patients in immune‐tolerant phase of chronic hepatitis B virus infection: A systematic review and meta‐analysis;Reviews in Medical Virology;2024-07

3. Lower HBV DNA level is associated with more severe liver fibrosis in HBeAg-positive chronic hepatitis B with normal alanine transaminase;Virology Journal;2024-06-04

4. Treatment decisions based on HBV DNA;Journal of Viral Hepatitis;2024-05-24

5. Letter: Association of persistently high HBsAg levels during HBeAg‐seropositive stage and hepatocellular carcinoma risk in chronic hepatitis B patients—Authors' reply;Alimentary Pharmacology & Therapeutics;2024-04-25